News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS) Receives EU Approval for Gilenya



3/21/2011 6:33:59 AM

ZURICH, March 21 (Reuters) - Swiss drugmaker Novartis AG (NOVN.VX) said the European Commission approved its multiple sclerosis pill Gilenya, a potential blockbuster that should help it cope with price pressures and competition from generics.

Read at Reuters
Read at Bloomberg
Read at Market Watch
Read at Forbes


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES